Advertisement
Australia markets closed
  • ALL ORDS

    8,013.80
    +11.00 (+0.14%)
     
  • ASX 200

    7,767.50
    +7.90 (+0.10%)
     
  • AUD/USD

    0.6655
    +0.0004 (+0.06%)
     
  • OIL

    82.61
    +0.87 (+1.06%)
     
  • GOLD

    2,339.90
    +3.30 (+0.14%)
     
  • Bitcoin AUD

    92,374.00
    +510.45 (+0.56%)
     
  • CMC Crypto 200

    1,278.56
    -5.27 (-0.41%)
     
  • AUD/EUR

    0.6214
    +0.0008 (+0.13%)
     
  • AUD/NZD

    1.0944
    +0.0018 (+0.16%)
     
  • NZX 50

    11,717.43
    -117.59 (-0.99%)
     
  • NASDAQ

    19,789.03
    +37.98 (+0.19%)
     
  • FTSE

    8,225.34
    +45.66 (+0.56%)
     
  • Dow Jones

    39,164.06
    +36.26 (+0.09%)
     
  • DAX

    18,333.20
    +122.65 (+0.67%)
     
  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     

The past three years for TrueBlue (NYSE:TBI) investors has not been profitable

If you love investing in stocks you're bound to buy some losers. But the long term shareholders of TrueBlue, Inc. (NYSE:TBI) have had an unfortunate run in the last three years. Unfortunately, they have held through a 64% decline in the share price in that time. And over the last year the share price fell 42%, so we doubt many shareholders are delighted. Furthermore, it's down 14% in about a quarter. That's not much fun for holders.

So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.

See our latest analysis for TrueBlue

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

ADVERTISEMENT

Over the three years that the share price declined, TrueBlue's earnings per share (EPS) dropped significantly, falling to a loss. Due to the loss, it's not easy to use EPS as a reliable guide to the business. However, we can say we'd expect to see a falling share price in this scenario.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

earnings-per-share-growth
earnings-per-share-growth

We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Dive deeper into the earnings by checking this interactive graph of TrueBlue's earnings, revenue and cash flow.

A Different Perspective

Investors in TrueBlue had a tough year, with a total loss of 42%, against a market gain of about 24%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 9% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Investors who like to make money usually check up on insider purchases, such as the price paid, and total amount bought. You can find out about the insider purchases of TrueBlue by clicking this link.

TrueBlue is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com